| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031859 Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same |
| 02/08/2007 | US20070031844 Functional and hyperfunctional siRNA |
| 02/08/2007 | US20070031485 Pharmaceutical composition having a cationic excipient |
| 02/08/2007 | US20070031454 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 02/08/2007 | US20070031452 rheumatoid arthritis; nervous system disorders; endogenous retroviral elements (ERV) |
| 02/08/2007 | US20070031445 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 02/08/2007 | US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 02/08/2007 | US20070031421 Inhibitors targeting osteoclast-associated protein |
| 02/08/2007 | US20070031419 Methods and compositions for treating diseases targeting CDCP1 |
| 02/08/2007 | US20070031417 Dicer interacting proteins and uses therefor |
| 02/08/2007 | US20070031396 Method of treating neurological diseases |
| 02/08/2007 | US20070031392 Delivery vehicle for recombinant proteins |
| 02/08/2007 | US20070031391 Using genetically engineered neural stem cells to track metastatic brain tumor cells by migrating throughout a brain tumor; antitumor agents |
| 02/08/2007 | US20070031390 Methods and compositions for site-specific genomic expression of nucleic acid sequences |
| 02/08/2007 | US20070031389 Using cardiac graft to treat and prevent scar tissue on heart; tissue engineering and regenerative medicine |
| 02/08/2007 | US20070031386 culturing a multilayer of human embryonic stem cells for a sufficient time to allow for the appearance of putative cells comprising brown pigment dispersed within their cytoplasm, culturing the putative cells to form a cell monolayer containing cells that are Pax6 negative and bestrophin positive |
| 02/08/2007 | US20070031383 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 02/08/2007 | US20070031382 Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
| 02/08/2007 | US20070031381 Recombinant adenoviral vector and method of use |
| 02/08/2007 | US20070031380 Integration-site directed vector systems |
| 02/08/2007 | US20070031379 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same |
| 02/08/2007 | US20070031378 Minicircle vector production |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | DE102005036542A1 CTL-Prodrug CTL prodrug |
| 02/08/2007 | CA2617578A1 Methods and compositions for regenerating articular cartilage |
| 02/08/2007 | CA2616891A1 Hepatitis c antivirals |
| 02/08/2007 | CA2585267A1 Modified bacteriophage vectors and uses thereof |
| 02/07/2007 | EP1749884A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 02/07/2007 | EP1749836A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/07/2007 | EP1749835A2 Protective antigens and vaccines for the control of multi species tick infestations |
| 02/07/2007 | EP1749530A2 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods [1998/31] |
| 02/07/2007 | EP1749098A2 Chimeric adenoviruses for use in cancer treatment |
| 02/07/2007 | EP1749097A2 Replication competent viruses capable of silencing virus inhibitory factor expression |
| 02/07/2007 | EP1748792A1 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same |
| 02/07/2007 | EP1311675B1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 02/07/2007 | EP1141308B1 Group b streptococcus proteins, and their use |
| 02/07/2007 | EP0948646B1 Methods for identifying genes essential to the growth of an organism |
| 02/07/2007 | EP0909272B1 Helicobacter pylori adhesin binding group antigen |
| 02/07/2007 | CN1910456A Marker for neuromyelitis optica |
| 02/07/2007 | CN1909927A Method of suppressing cancer |
| 02/07/2007 | CN1909920A Method for the delivery of sustained release agents |
| 02/07/2007 | CN1909918A T cell immunoreaction inhibitor |
| 02/07/2007 | CN1908187A Application of protein arginine methyl transferase 5 in cell detection and treatment of leukemia |
| 02/07/2007 | CN1908170A Lim mineralization protein splice variants |
| 02/07/2007 | CN1907495A Application of Resistin binding polypeptide for preparing medicine promoting insulin secretion |
| 02/07/2007 | CN1907494A Polybutylcyanoacrylate nano-granule with resolubity, its application and use thereof |
| 02/07/2007 | CN1298851C Polypeptide |
| 02/07/2007 | CN1298388C 单纯疱疹病毒ⅱ型dna疫苗 Herpes simplex virus type ⅱ dna vaccine |
| 02/06/2007 | US7173122 Antisense oligonucleotides to type I procollagen |
| 02/06/2007 | US7173117 Codon optimised recombinant Dermaphagoides allergens |
| 02/06/2007 | US7173116 Nucleic acid formulations for gene delivery and methods of use |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7173015 Inhibition of Syk kinase expression |
| 02/06/2007 | US7173010 Orphanin FQ receptor |
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172892 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 02/06/2007 | US7172869 Increasing expression of exogenous nucleotide sequences via lymphocyte activation prior to gene transfer to cells |
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/06/2007 | CA2349594C Cells for the production of helper dependent adenoviral vectors |
| 02/06/2007 | CA2274146C Genetic modification of primate hemopoietic repopulating stem cells |
| 02/01/2007 | WO2007014370A2 Small regulatory rnas and methods of use |
| 02/01/2007 | WO2007014150A2 Method of administering liposomes containing oligonucleotides |
| 02/01/2007 | WO2007014122A2 Treated feed supplement capsule for ruminants |
| 02/01/2007 | WO2007014077A2 Rnai modulation of the rho-a gene and uses thereof |
| 02/01/2007 | WO2007014075A2 Rnai modulation of the rho-a gene in research models |
| 02/01/2007 | WO2007013603A1 Lymphangiogenesis promoter |
| 02/01/2007 | WO2007013593A1 Method for diagnosis of gastric cancer utilizing methylation of novel gene acmg1 as index |
| 02/01/2007 | WO2007013438A1 Anti-obesity agent and anti-obesity food |
| 02/01/2007 | WO2007013411A1 Anti-sense nucleic acid derived from organism |
| 02/01/2007 | WO2007012944A2 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 02/01/2007 | WO2007012191A1 Systems and methods for manufacturing liposomes |
| 02/01/2007 | WO2006094722A3 Growth factor mutants with improved biological activity |
| 02/01/2007 | WO2006039656A3 Modified small interfering rna molecules and methods of use |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027103 Methods and compositions for silencing genes without inducing toxicity |
| 02/01/2007 | US20070027102 Methods and compositions for treating macular degeneration |
| 02/01/2007 | US20070027101 Treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy |
| 02/01/2007 | US20070027100 Use of placental growth factor for preventing or treating ischemic diseases or stroke |
| 02/01/2007 | US20070027099 Gene therapy of HBV infection via adeno-associated viral vector mediated long term expression of small hairpin RNA (shRNA) |
| 02/01/2007 | US20070027098 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 02/01/2007 | US20070027097 Small interfering RNA with improved activity |
| 02/01/2007 | US20070027096 Aptamers to human epidermal growth factor receptor-3 |
| 02/01/2007 | US20070027084 Novel Integrin Ligand ITGL-TSP |
| 02/01/2007 | US20070027082 Intracellular interleukin-1 receptor antagonist and uses thereof |
| 02/01/2007 | US20070027075 Compositions and methods for targeted drug delivery |
| 02/01/2007 | US20070026515 Cell or drug encapsulation device having a wet seal |
| 02/01/2007 | US20070026499 nucleotide or DNA constructs comprising expression cassettes comprising promoters operably linked to transgene open reading frames, used in protein production, diagnostics, transgenic plants and animals and the therapeutic field |
| 02/01/2007 | US20070026498 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/01/2007 | US20070026495 Novel Integrin Ligand ITGL-TSP |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026436 Glucose transport-related genes, polypeptides, and methods of use thereof |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026394 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies |
| 02/01/2007 | US20070026076 Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins |
| 02/01/2007 | US20070026044 Use of VEGF For Treating Bone Defects |
| 02/01/2007 | US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease |